Announcements Trials
Browse Landscape

Phase

Phase 1 43Phase 2 15Phase 1/2 6Phase NA 2Phase 3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 1195INDUSTRY 36OTHER_GOV 27NETWORK 7FED 5NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 39Genitourinary 28Lymphoid 26CNS 23Thoracic 21Other hematologic neoplasm 21Gastrointestinal 21Other solid neoplasm 17Gynecologic 17Sarcoma 14Dermatologic 11Head & Neck 9Myeloid 8Plasma cell 6Other 4Endocrine 4Tumor-Agnostic 2Other neoplasm 2Classical hematology 2

Conditions

Neoplasms 2

Interventions

Technetium Tc 99m Sestamibi 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × NIH × Tumor-Agnostic × Clear all
NCT05909202 2026-04-20

A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

National Institutes of Health Clinical Center (CC)

Phase NA Completed
28 enrolled
Tumor-Agnostic

Neoplasms

NCT00972205 2012-07-19

Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase NA Completed
12 enrolled 12 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡